RE: Heavily Oversold17 Jan 2022 16:21
Exactly Aldebaran. The LFT is what pumped the price here. Like you say, the SP was in the teens before covid. AVA6000 arriving at a point where it's worth anything is many, many years away. Massive near term revenue is what gets the market excited, not vague news on a drug (however revolutionary it may be) that is donkeys years away. AVA6000 has progressed by a few small steps in the last two years and there's an incredibly long and risky road ahead for it. Alastair saying he's pleased means nothing as we all know by now. He's been pleased about the LFT for two years and has made a complete hash of it. The only thing Alastair is genuinely pleased about is his nice shiny house.
As I've said for a while now. Given the money raised and the slight progression that's been made in the last few years, it's fair to attribute more value to AVCT than where it was trading prior to covid, say about double, but it's not worth more than that until it's actually delivers something properly. I would say somewhere between 25p and 40p would be fair here. If they get the LFT sorted maybe 50p to 60p.
Alastair needs to prove to the market he's not a constantly bungling fool who's only real success has been buying himself a house while telling shareholders everything was progressing well as he sold.